BioInnovation Institute & Science Prize for Innovation
0 comments
by Amanda Clifford
Through the BioInnovation Institute Science Prize for Innovation, the editors of Science seek to recognize bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship...
Call for Applications: CBS Mentorship And Professional Development Program
0 comments
by Amanda Clifford
We are pleased to open the call for applications for the CBS Mentorship and Professional Development, a program specifically designed to connect professionals outside of academia with graduate students and postdoctoral fellows coming from the Canadian biomaterial s community...
14th Intl Symposium on Biodegradable Metals for Biomedical Applications
0 comments
by Neda Latifi
14th Intl Symposium on Biodegradable Metals for Applications on behalf of Professor Mantovani and the Quebec City Student Chapter Want to discover the next generation of bioresorbable metals aiming to bridge the gap between biomaterials and tissue engineering for pediatric, dental, orthopedic, vascular, cardiac, neurological applications, and more? The final program of the upcoming 14th Intl Symposium on Biodegradable Metals for Biomedical Applications is now online...
Women in the Business of Health Science Bootcamp
0 comments
by Neda Latifi
Dear CBS members on behalf of the OBIO WiHI Program , The OBIO Women in the Business of Health Science Bootcamp will take place between September 12 16, 2022, and is available at no cost to eligible applicants...
Recent advances in 3D microfluidic based bioprinting have enabled manufacturing of complex structures with controlled architectures and tunable properties...
Vascular development is extensively studied in small animals with the goal of increasing our understanding of this process and applying what is learned to humans...
Doxorubicin is widespread and influential apoptosis-inducing drug in cancer chemotherapy which interdicts DNA replication and treats different types of cancers including, benign, potentially-malignant, glioblastoma malignant tumours 1 2 3 ...
Conventional drug screening is performed on cells cultured on 2D, stiff poly styrene , which provides an environment that misrepresents the morphology and growth characteristics of patient tumours...
